Lung-I Cheng

Lung-I Cheng is Vice President, Cell and Gene Therapy, leading AmerisourceBergen’s Cell and Gene Therapy (CGT) service line within Commercial Solutions.

He is responsible for leading a unified CGT go-to-market strategy that addresses external customer needs, and provides integrated solutions that deliver the right resources at the right time to position therapies for success.

Before joining AmerisourceBergen, he spent a decade in biopharma and most recently led Takeda Oncology’s global value and access team in cell therapies and pipeline.